MedPath

A head to head comparison of aripiprazole versus olanzaoine as adjvants to lithium for treating manic or mixed episodes in bipolar disorder

Phase 3
Completed
Conditions
Bipolar mood disorder manic or mixed phase.
Manic episode
Registration Number
IRCT201305213930N25
Lead Sponsor
Vice chancellor for research, Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

patients from both gender aged 16 to 65 years old with bipolar mood disorder-type I- manic phase.
Exclusion criteria: sever uncontrolled medical conditions such as hypothyroidism; positive history of allergy to one of the medications.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical symptoms of mania. Timepoint: baseline, week 1, week 3, and week 3. Method of measurement: Interview, Young Mania Rating Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath